395 related articles for article (PubMed ID: 26746191)
1. Pivotal Role for CD16+ Monocytes in Immune Surveillance of the Central Nervous System.
Waschbisch A; Schröder S; Schraudner D; Sammet L; Weksler B; Melms A; Pfeifenbring S; Stadelmann C; Schwab S; Linker RA
J Immunol; 2016 Feb; 196(4):1558-67. PubMed ID: 26746191
[TBL] [Abstract][Full Text] [Related]
2. Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis.
Chuluundorj D; Harding SA; Abernethy D; La Flamme AC
Immunol Cell Biol; 2014 Jul; 92(6):509-17. PubMed ID: 24638064
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of CNS Viral Seeding by HIV
Veenstra M; León-Rivera R; Li M; Gama L; Clements JE; Berman JW
mBio; 2017 Oct; 8(5):. PubMed ID: 29066542
[TBL] [Abstract][Full Text] [Related]
4. Elevated circulating CD14
Peng A; Ke P; Zhao R; Lu X; Zhang C; Huang X; Tian G; Huang J; Wang J; Invernizzi P; Chen Q; Zhuang J
Clin Exp Med; 2016 Nov; 16(4):511-521. PubMed ID: 26403460
[TBL] [Abstract][Full Text] [Related]
5. Frontline Science: CXCR7 mediates CD14
Veenstra M; Williams DW; Calderon TM; Anastos K; Morgello S; Berman JW
J Leukoc Biol; 2017 Nov; 102(5):1173-1185. PubMed ID: 28754798
[TBL] [Abstract][Full Text] [Related]
6. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions.
Ancuta P; Moses A; Gabuzda D
Immunobiology; 2004; 209(1-2):11-20. PubMed ID: 15481136
[TBL] [Abstract][Full Text] [Related]
7. Modulatory effects of CD14+CD16++ monocytes on CD14++CD16- monocytes: a possible explanation of monocyte alterations in systemic lupus erythematosus.
Burbano C; Vasquez G; Rojas M
Arthritis Rheumatol; 2014 Dec; 66(12):3371-81. PubMed ID: 25168844
[TBL] [Abstract][Full Text] [Related]
8. GM-CSF promotes migration of human monocytes across the blood brain barrier.
Vogel DY; Kooij G; Heijnen PD; Breur M; Peferoen LA; van der Valk P; de Vries HE; Amor S; Dijkstra CD
Eur J Immunol; 2015 Jun; 45(6):1808-19. PubMed ID: 25756873
[TBL] [Abstract][Full Text] [Related]
9. Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls.
Chuluundorj D; Harding SA; Abernethy D; La Flamme AC
Immunol Cell Biol; 2017 Mar; 95(3):297-305. PubMed ID: 27694998
[TBL] [Abstract][Full Text] [Related]
10. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis.
Zimmermann HW; Seidler S; Nattermann J; Gassler N; Hellerbrand C; Zernecke A; Tischendorf JJ; Luedde T; Weiskirchen R; Trautwein C; Tacke F
PLoS One; 2010 Jun; 5(6):e11049. PubMed ID: 20548789
[TBL] [Abstract][Full Text] [Related]
11. Circulating classical CD14++CD16- monocytes predict shorter time to initial treatment in chronic lymphocytic leukemia patients: Differential effects of immune chemotherapy on monocyte-related membrane and soluble forms of CD163.
Lapuc I; Bolkun L; Eljaszewicz A; Rusak M; Luksza E; Singh P; Miklasz P; Piszcz J; Ptaszynska-Kopczynska K; Jasiewicz M; Kaminski K; Dabrowska M; Bodzenta-Lukaszyk A; Kloczko J; Moniuszko M
Oncol Rep; 2015 Sep; 34(3):1269-78. PubMed ID: 26135617
[TBL] [Abstract][Full Text] [Related]
12. Human monocyte heterogeneity--a nephrological perspective.
Rogacev KS; Heine GH
Nephrol Ther; 2010 Jul; 6(4):219-25. PubMed ID: 20447885
[TBL] [Abstract][Full Text] [Related]
13. CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection.
Fischer-Smith T; Croul S; Sverstiuk AE; Capini C; L'Heureux D; Régulier EG; Richardson MW; Amini S; Morgello S; Khalili K; Rappaport J
J Neurovirol; 2001 Dec; 7(6):528-41. PubMed ID: 11704885
[TBL] [Abstract][Full Text] [Related]
14. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals.
Williams DW; Anastos K; Morgello S; Berman JW
J Leukoc Biol; 2015 Feb; 97(2):401-12. PubMed ID: 25420915
[TBL] [Abstract][Full Text] [Related]
15. CD16⁺ monocytes with smooth muscle cell characteristics are reduced in human renal chronic transplant dysfunction.
Boersema M; van den Born JC; van Ark J; Harms G; Seelen MA; van Dijk MC; van Goor H; Navis GJ; Popa ER; Hillebrands JL
Immunobiology; 2015 May; 220(5):673-83. PubMed ID: 25476849
[TBL] [Abstract][Full Text] [Related]
16. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder.
Kong BS; Kim Y; Kim GY; Hyun JW; Kim SH; Jeong A; Kim HJ
J Neuroinflammation; 2017 Sep; 14(1):191. PubMed ID: 28946890
[TBL] [Abstract][Full Text] [Related]
17. The "Intermediate" CD14
Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
[TBL] [Abstract][Full Text] [Related]
18. Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis.
Gjelstrup MC; Stilund M; Petersen T; Møller HJ; Petersen EL; Christensen T
Immunol Cell Biol; 2018 Feb; 96(2):160-174. PubMed ID: 29363161
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in the Locomotory Behavior of Human Monocyte Subsets over Human Vascular Endothelium In Vitro.
Collison JL; Carlin LM; Eichmann M; Geissmann F; Peakman M
J Immunol; 2015 Aug; 195(3):1162-70. PubMed ID: 26085686
[TBL] [Abstract][Full Text] [Related]
20. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
